Showing results (721-730 of 4,871) with videos related to
Sort By:
Pageof 488
Urologic Oncology|January 9, 2007
Multilocular cystadenoma and cystadenocarcinoma of the prostateTomasz Tuziak, Philippe E Spiess, Neil A Abrahams, et al.Urologic Oncology|January 9, 2007
Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicityEna Segota, Tarek Mekhail, Thomas Olencki, et al.Urologic Oncology|January 9, 2007
Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancerJohn J Coen, Anthony L Zietman, Donald S Kaufman, et al.Urologic Oncology|December 2, 2006
Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinomaLance C Pagliaro, Cherie A Perez, Shi-Ming Tu, et al.Urologic Oncology|December 23, 2008
Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based surveyAlan M Nieder, Yair Lotan, Geoffrey R Nuss, et al.Urologic Oncology|July 16, 2008
Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapyAndreas Meyer, Peter Schürmann, Maryam Ghahremani, et al.Urologic Oncology|June 20, 2008
Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancerDeepika Dhawan, José A Ramos-Vara, Jane C Stewart, et al.Urologic Oncology|March 11, 2009
The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancerPriscila M Andrade, Daher C Chade, Ricardo C Borra, et al.Urologic Oncology|March 11, 2009
The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancersHervé Wallerand, Grégoire Robert, Gilles Pasticier, et al.Pageof 488